Funded Tech Companies
Pep2Tango Therapeutics
Pep2Tango Therapeutics, based in Potomac, received equity investments from Versant Ventures.
Company Overview
Company Name
Pep2Tango Therapeutics
Company Status
Private & Independent
Industry
Life Sciences
Funding Rounds
Total Funding
Contact Information
Company Background Information
Overview
Pep2Tango Therapeutics is a biotech company developing superior unimolecular multi-receptor agonists for obesity and related disorders. Their lead program in obesity is a first-in-class tetra-receptor peptide agonist peptide that shows superiority to Tirzepatide for weight loss in obesity animal models. Other key product differentiation attributes include selective weight loss from fat mass with preservation of lean mass / muscle. With their cutting-edge peptide platform and promising pipeline, Pep2Tango aims to revolutionize obesity and metabolic disease treatment with better, safer, and more effective therapies.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
11/22/2024
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Cristina Rondinone
Company Investors
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs